pharmatechoutlook
DECEMBER - 20225IN MY OPINIONLAST WORDC O NT E NT STimothy White,Vice President and Head of Global Digital Commercial, Teva PharmaceuticalsThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson,Senior Director,Chemical Research & Development,Pfizer [NYSE:PFE]Avoiding the `Shiny Object' Trap of Digital Transformation TOP 10 TECH OUTLOOKCOMPANIES - 2022PHARMACONSULTINGScott Rosenberry, Partner/VP,Business DevelopmentTodd Applebaum,Managing DirectorConverge Consulting18Featured Companies22Dr. Paul O'Shea,Co-Founder and Chief Scientific OfficerYadan Chen,Co-Founder and Chief Executive OfficerExemplify BioPharma27David Hahn, Worldwide HeadThe Medical Affairs Company0830Catherine Baldridge, Head of Safety Affairs Sid Senroy,Founder & PresidentRegDev, Inc25Greg Coir,Executive Vice President Eliassen Group21
< Page 4 | Page 6 >